These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 25622018)
41. Bovine lactoferricin causes apoptosis in Jurkat T-leukemia cells by sequential permeabilization of the cell membrane and targeting of mitochondria. Mader JS; Richardson A; Salsman J; Top D; de Antueno R; Duncan R; Hoskin DW Exp Cell Res; 2007 Jul; 313(12):2634-50. PubMed ID: 17570361 [TBL] [Abstract][Full Text] [Related]
42. Semi-preparative isolation of dihydroresveratrol-3-O-β-d-glucuronide and four resveratrol conjugates from human urine after oral intake of a resveratrol-containing dietary supplement. Radko Y; Christensen KB; Christensen LP J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jul; 930():54-61. PubMed ID: 23727867 [TBL] [Abstract][Full Text] [Related]
43. Resveratrol selectively inhibits leukemia cells: a prospective agent for ex vivo bone marrow purging. Gautam SC; Xu YX; Dumaguin M; Janakiraman N; Chapman RA Bone Marrow Transplant; 2000 Mar; 25(6):639-45. PubMed ID: 10734298 [TBL] [Abstract][Full Text] [Related]
44. The design, synthesis, and anti-tumor mechanism study of N-phosphoryl amino acid modified resveratrol analogues. Liu H; Dong A; Gao C; Tan C; Liu H; Zu X; Jiang Y Bioorg Med Chem; 2008 Dec; 16(23):10013-21. PubMed ID: 18952444 [TBL] [Abstract][Full Text] [Related]
45. Inhibition of gastric cancer cell proliferation by resveratrol: role of nitric oxide. Holian O; Wahid S; Atten MJ; Attar BM Am J Physiol Gastrointest Liver Physiol; 2002 May; 282(5):G809-16. PubMed ID: 11960777 [TBL] [Abstract][Full Text] [Related]
46. Resveratrol-induced cellular apoptosis and cell cycle arrest in neuroblastoma cells and antitumor effects on neuroblastoma in mice. Chen Y; Tseng SH; Lai HS; Chen WJ Surgery; 2004 Jul; 136(1):57-66. PubMed ID: 15232540 [TBL] [Abstract][Full Text] [Related]
47. The pterocarpanquinone LQB 118 induces apoptosis in tumor cells through the intrinsic pathway and the endoplasmic reticulum stress pathway. de Sá Bacelar T; da Silva AJ; Costa PR; Rumjanek VM Anticancer Drugs; 2013 Jan; 24(1):73-83. PubMed ID: 22960938 [TBL] [Abstract][Full Text] [Related]
48. Apoptogenic activity of 2α,3α-dihydroxyurs-12-ene-28-oic acid from Prunella vulgaris var. lilacina is mediated via mitochondria-dependent activation of caspase cascade regulated by Bcl-2 in human acute leukemia Jurkat T cells. Woo HJ; Jun do Y; Lee JY; Woo MH; Yang CH; Kim YH J Ethnopharmacol; 2011 Jun; 135(3):626-35. PubMed ID: 21473903 [TBL] [Abstract][Full Text] [Related]
49. Effects of (15S)-hydroperoxyeicosatetraenoic acid and (15S)-hydroxyeicosatetraenoic acid on the acute- lymphoblastic-leukaemia cell line Jurkat: activation of the Fas-mediated death pathway. Kumar KA; Arunasree KM; Roy KR; Reddy NP; Aparna A; Reddy GV; Reddanna P Biotechnol Appl Biochem; 2009 Feb; 52(Pt 2):121-33. PubMed ID: 18494609 [TBL] [Abstract][Full Text] [Related]
50. Resveratrol induces apoptosis and differentiation in acute promyelocytic leukemia (NB4) cells. Cao Y; Wang F; Liu HY; Fu ZD; Han R J Asian Nat Prod Res; 2005 Aug; 7(4):633-41. PubMed ID: 16087638 [TBL] [Abstract][Full Text] [Related]
51. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Aggarwal BB; Bhardwaj A; Aggarwal RS; Seeram NP; Shishodia S; Takada Y Anticancer Res; 2004; 24(5A):2783-840. PubMed ID: 15517885 [TBL] [Abstract][Full Text] [Related]
52. Increased transport of resveratrol across monolayers of the human intestinal Caco-2 cells is mediated by inhibition and saturation of metabolites. Maier-Salamon A; Hagenauer B; Wirth M; Gabor F; Szekeres T; Jäger W Pharm Res; 2006 Sep; 23(9):2107-15. PubMed ID: 16952002 [TBL] [Abstract][Full Text] [Related]
53. Physiological Relevance of the Antiproliferative and Estrogenic Effects of Dietary Polyphenol Aglycones versus Their Phase-II Metabolites on Breast Cancer Cells: A Call of Caution. Ávila-Gálvez MÁ; Espín JC; González-Sarrías A J Agric Food Chem; 2018 Aug; 66(32):8547-8555. PubMed ID: 30025453 [TBL] [Abstract][Full Text] [Related]
54. Interactions of resveratrol and its metabolites (resveratrol-3-sulfate, resveratrol-3-glucuronide, and dihydroresveratrol) with serum albumin, cytochrome P450 enzymes, and OATP transporters. Poór M; Kaci H; Bodnárová S; Mohos V; Fliszár-Nyúl E; Kunsági-Máté S; Özvegy-Laczka C; Lemli B Biomed Pharmacother; 2022 Jul; 151():113136. PubMed ID: 35594715 [TBL] [Abstract][Full Text] [Related]
55. Resveratrol metabolites have an antiproliferative effect on intestinal epithelial cancer cells. Storniolo CE; Moreno JJ Food Chem; 2012 Oct; 134(3):1385-91. PubMed ID: 25005957 [TBL] [Abstract][Full Text] [Related]
56. Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. Patel KR; Brown VA; Jones DJ; Britton RG; Hemingway D; Miller AS; West KP; Booth TD; Perloff M; Crowell JA; Brenner DE; Steward WP; Gescher AJ; Brown K Cancer Res; 2010 Oct; 70(19):7392-9. PubMed ID: 20841478 [TBL] [Abstract][Full Text] [Related]
57. Anti-tumor and immunomodulatory activity of resveratrol in vitro and its potential for combining with cancer immunotherapy. Soto BL; Hank JA; Darjatmoko SR; Polans AS; Yanke EM; Rakhmilevich AL; Seo S; Kim K; Reisfeld RA; Gillies SD; Sondel PM Int Immunopharmacol; 2011 Nov; 11(11):1877-86. PubMed ID: 21854876 [TBL] [Abstract][Full Text] [Related]
58. Resveratrol given intraperitoneally does not inhibit the growth of high-risk t(4;11) acute lymphoblastic leukemia cells in a NOD/SCID mouse model. Zunino SJ; Storms DH; Newman JW; Pedersen TL; Keen CL; Ducore JM Int J Oncol; 2012 Apr; 40(4):1277-84. PubMed ID: 22200740 [TBL] [Abstract][Full Text] [Related]
59. Resveratrol and its metabolites elicit neuroprotection via high-affinity binding to the laminin receptor at low nanomolar concentrations. Gopalakrishna R; Aguilar J; Oh A; Lee E; Hou L; Lee T; Xu E; Nguyen J; Mack WJ FEBS Lett; 2024 May; 598(9):995-1007. PubMed ID: 38413095 [TBL] [Abstract][Full Text] [Related]
60. In vivo-formed versus preformed metabolite kinetics of trans-resveratrol-3-sulfate and trans-resveratrol-3-glucuronide. Sharan S; Iwuchukwu OF; Canney DJ; Zimmerman CL; Nagar S Drug Metab Dispos; 2012 Oct; 40(10):1993-2001. PubMed ID: 22807110 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]